Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study

Phase Iii ◽

Open Phase ◽

Multi Center Study ◽

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study

Human Vaccines & Immunotherapeutics ◽

10.1080/21645515.2021.1902701 ◽

2021 ◽

pp. 1-10

Author(s):

Franco M. Piazza ◽

Miia Virta ◽

Marita Paassilta ◽

Benita Ukkonen ◽

Anitta Ahonen ◽

...

Keyword(s):

Conjugate Vaccine ◽

Meningococcal Disease ◽

Booster Dose ◽

Phase Iii ◽

Open Label ◽

Multi Center Study ◽

Quadrivalent Meningococcal Conjugate Vaccine ◽

Follow-up results of a randomized, double-blind, phase III, multi-center study to evaluate the safety and efficacy of BF-200 ALA versus placebo in field-directed treatment of mild to moderate AK with photodynamic therapy when using narrowband red light

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.3.supp.49 ◽

2019 ◽

Vol 3 ◽

pp. S49

Author(s):

U Reinhold ◽

T Dirschka ◽

R Ostendorf ◽

R Aschoff ◽

C Berking ◽

...

Keyword(s):

Photodynamic Therapy ◽

Red Light ◽

Phase Iii ◽

Double Blind ◽

Safety And Efficacy ◽

Multi Center Study ◽

Abstract not available.

A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults

Vaccine ◽

10.1016/j.vaccine.2010.10.025 ◽

2010 ◽

Vol 29 (1) ◽

pp. 45-50 ◽

Cited By ~ 48

Author(s):

Robert Booy ◽

Olivier Van Der Meeren ◽

Su-Peing Ng ◽

Froilan Celzo ◽

Gunasekaran Ramakrishnan ◽

...

Keyword(s):

Pertussis Vaccine ◽

Booster Dose ◽

Acellular Pertussis Vaccine

Corrigendum to ‘Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults’. [Vaccine 36 (2018) 6325–6333]

Vaccine ◽

10.1016/j.vaccine.2020.01.082 ◽

2020 ◽

Vol 38 (12) ◽

pp. 2746-2747

Author(s):

Donald Brandon ◽

Murray Kimmel ◽

Sherine O. Kuriyakose ◽

Lusiné Kostanyan ◽

Narcisa Mesaros

Keyword(s):

Pertussis Vaccine ◽

Booster Dose ◽

Booster Vaccination ◽

Antibody Persistence

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study

Human Vaccines & Immunotherapeutics ◽

10.1080/21645515.2020.1796423 ◽

2020 ◽

pp. 1-8

Author(s):

Asmik Asatryan ◽

Nadia Meyer ◽

Michael Scherbakov ◽

Victor Romanenko ◽

Irina Osipova ◽

...

Keyword(s):

Pertussis Vaccine ◽

Vaccine Dose ◽

Phase Iii ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Booster Vaccine

A Modified Vaccine Reduces the Rate of Large Injection Site Reactions to the Preschool Booster Dose of Diphtheria-Tetanus-Acellular Pertussis Vaccine

The Pediatric Infectious Disease Journal ◽

10.1097/01.inf.0000190028.96152.46 ◽

2005 ◽

Vol 24 (12) ◽

pp. 1059-1066 ◽

Cited By ~ 28

Author(s):

David W. Scheifele ◽

Scott A. Halperin ◽

Jan J. Ochnio ◽

Alexander C. Ferguson ◽

Danuta M. Skowronski

Keyword(s):

Injection Site ◽

Pertussis Vaccine ◽

Booster Dose ◽

Injection Site Reactions ◽

Large Injection

A randomized phase III study of rubitecan (ORA) vs. best choice (BC) in 409 patients with refractory pancreatic cancer report from a North-American multi-center study

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4013 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4013-4013 ◽

Cited By ~ 24

Author(s):

A. D. Jacobs ◽

H. A. Burris ◽

S. Rivkin ◽

P. S. Ritch ◽

P. D. Eisenberg ◽

...

Keyword(s):

Pancreatic Cancer ◽

North American ◽

Phase Iii ◽

Phase Iii Study ◽

Multi Center Study ◽

Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age

The Journal of Pediatrics ◽

10.1016/s0022-3476(97)70247-6 ◽

1997 ◽

Vol 130 (4) ◽

pp. 616-623 ◽

Cited By ~ 44

Author(s):

Heinz-J. Schmitt ◽

Karin Beutel ◽

Anne Schuind ◽

Markus Knuf ◽

Sabine Wagner ◽

...

Keyword(s):

Pertussis Vaccine ◽

Booster Dose ◽

Acellular Pertussis Vaccine

Erratum to ???A Modified Vaccine Reduces the Rate of Large Injection Site Reactions to the Preschool Booster Dose of Diphtheria-Tetanus-Acellular Pertussis Vaccine.??? D. W. Scheifele et al.

The Pediatric Infectious Disease Journal ◽

10.1097/00006454-200603000-00012 ◽

2006 ◽

Vol 25 (3) ◽

pp. 229

Author(s):

&NA;

Keyword(s):

Injection Site ◽

Pertussis Vaccine ◽

Booster Dose ◽

Injection Site Reactions ◽

Large Injection

FRI0135 INTRAVENOUS PEGYLATED LIPOSOMAL PREDNISOLONE SODIUM PHOSPHATE MORE EFFECTIVE THAN INTRAMUSCULAR INJECTION OF METHYLPREDNISOLONE ACETATE IN TREATING RA PATIENTS WHO ARE EXPERIENCING A FLARE: A PHASE III, RANDOMIZED, DOUBLE-BLIND, DOUBLE DUMMY, ACTIVE CONTROLLED, MULTI-CENTER STUDY

10.1136/annrheumdis-2019-eular.4052 ◽

2019 ◽

Author(s):

Johannes W.J. Bijlsma ◽

Bart Metselaar ◽

Leonie Middelink ◽

Cees Wortel ◽

Reinhard Bos ◽

...

Keyword(s):

Intramuscular Injection ◽

Sodium Phosphate ◽

Phase Iii ◽

Methylprednisolone Acetate ◽

Double Blind ◽

Multi Center Study ◽